The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women.

Files in this item

There are no files associated with this item.

Find Full text

This item appears in the following Collection(s)

Share

Search ResearchSpace


Browse

Statistics